Ipsen $IPN.PA
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS19
PHASE 3 / 2-310
RECRUITING7
READOUTS ≤12 MONTHS6
READOUT SLIPPED >6 MO50%
Delay Index: of 14 active trials registered more than a year ago, 7 have moved their primary completion (readout) date by more than 6 months since first registration (median +9.0 months). See all sponsors →
Open Ipsen on the live radar map → 📅 $IPN.PA readout calendar (.ics)| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| ELATIVE NCT04526665 |
P3 | Active, not recruiting | Primary Biliary Cirrhosis | 161 | 2023-06-01 (-3 mo) |
| C-BEOND NCT06047444 |
P3 | Active, not recruiting | Chronic Migraine | 759 | 2026-05-28 (+12 mo) |
| E-BEOND NCT06047457 |
P3 | Active, not recruiting | Episodic Migraine | 751 | 2026-06-01 (+12 mo) |
| LAURITE 2 NCT07435428 |
P3 | Active, not recruiting | Moderate to Severe Glabellar Lines | 1300 | 2026-12-15 |
| LAURITE 1 NCT07427797 |
P3 | Active, not recruiting | Moderate to Severe Glabellar Lines | 309 | 2026-12-15 |
| ELONSEN NCT06730061 |
P3 | Active, not recruiting | Primary Biliary Cholangitis | 18 | 2026-12-17 (+9 mo) |
| CATALPA NCT06937931 |
P2 | Recruiting | Cervical Dystonia | 132 | 2027-03-26 (+14 mo) |
| LANTIC NCT04821089 |
P1/2 | Active, not recruiting | Moderate to Severe Upper Facial Lines | 727 | 2027-08-19 (+69 mo) |
| MERANTI NCT06625060 |
P2 | Active, not recruiting | Episodic Migraine; Chronic Migraine | 670 | 2027-10-31 (+5 mo) |
| IPN01194 NCT06305247 |
P1/2 | Active, not recruiting | Melanoma; Head and Neck Squamous Cell Carcinoma | 36 | 2028-03-20 |
| IPN01195 NCT06833008 |
P1/2 | Active, not recruiting | Advanced Solid Tumor | 42 | 2028-04-04 (-6 mo) |
| LAURITE 3 NCT07779252 |
P3 | Recruiting | Moderate to Severe Glabellar Lines | 160 | 2028-04-10 |
| IPN60300 NCT07213817 |
P1/2 | Recruiting | Locally Advanced Solid Tumor; Metastatic Solid Tumor | 114 | 2028-10-30 |
| LANTIMA NCT04752774 |
P1/2 | Recruiting | Spasticity | 240 | 2029-03-30 (+60 mo) |
| ELFIDENCE NCT06016842 |
P3 | Recruiting | Primary Biliary Cholangitis (PBC) | 276 | 2029-05-31 (-17 mo) |
| ELASCOPE NCT07387549 |
P3 | Recruiting | Primary Sclerosing Cholangitis | 350 | 2031-04-30 |
| EVICTION 3 NCT07623187 |
P2/3 | Not yet recruiting | Acute Myeloid Leukaemia (AML); Acute Myeloid Leukaemia | 540 | 2031-05-31 |
| ELMWOOD NCT05627362 |
P2 | Active, not recruiting | Primary Sclerosing Cholangitis | 68 | 2031-09-23 (+91 mo) |
| IPN01203 NCT07213830 |
P1/2 | Recruiting | Advanced Solid Tumor; Metastatic Solid Tumor | 102 | 2032-07-14 |